Companies Dominating the CRISPR and CAS Gene Technology Landscape
- Thermo Fisher Scientific Holdings, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Origene Technologies
- Addgene, Inc.
- Merck KGaA
- GenScript Biotech
- Cellecta, Inc.
- Caribou Bioscience, Inc.
- Horizon Discovery Group
- Mammoth Biosciences, Inc.
- Inscripta, Inc.
Browse Key Market Insights with Data Illustration:
In the News
- GenScript Biotech entered into an agreement with InnoBation Co. Ltd. for the cell line development and engineering of GMP plasmids and lentivirus. Through this agreement, GenScript is aiming to provide CRO services to InnoBation by using CRISPR and CAS gene technology.
- University of Connecticut Health Center developed “All-In-One Dual CRISPR-Cas 12a (AIOD-CRISPR)” assay method, which performs ultrasensitive, specific, and visual detection of nucleic acid in the SARS-COV-2 virus and can test for COVID-19 infection at a quicker pace.
- Mammoth Biosciences, Inc. developed a new CRISPR technology-based test for COVID- 19 detections called “SARS-COV-2 DETECTR”, which can take out results within an hour of the test using loop-mediated amplification and CAS12 enzyme.
